healthcare Targeting an ‘Energy Crisis’ in the Treatment of Non-Small Cell Lung Cancer By Staff Reports 1 year ago An energy crisis usually isn’t viewed as a positive situation, but when it comes to
Biotechnology cancer Cancer Discovery Uncategorized Identifying a New Therapeutic Target for the Most Common Type of Lung Cancer By Staff Reports 2 years ago Research by Rutgers Cancer Institute of New Jersey investigators has identified novel functions of the
Pharmaceutical Business News FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing By Staff Reports 2 years ago The U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients